← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2022-12-31 · Filed 2023-02-14 · Accession 0001420506-23-000696
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | ACADIA PHARMACEUTICALS INC | COM · 004225108 | LONG | 1,493,121 | $23.8 million |
| 2 | ACLARIS THERAPEUTICS INC | COM · 00461U105 | LONG | 2,393,985 | $37.7 million |
| 3 | ALECTOR INC | COM · 014442107 | LONG | 725,024 | $6.7 million |
| 4 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 219,930 | $46.4 million |
| 5 | ALLAKOS INC | COM · 01671P100 | LONG | 920,304 | $7.7 million |
| 6 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 112,250,000 | $103.1 million |
| 7 | ALX ONCOLOGY HLDGS INC | COM · 00166B105 | LONG | 258,280 | $2.9 million |
| 8 | AMGEN INC | COM · 031162100 | LONG | 131,100 | $34.4 million |
| 9 | AMYRIS INC | NOTE 1.500%11/1 · 03236MAJ0 | LONG | 137,850,000 | $43.3 million |
| 10 | ANAPTYSBIO INC | COM · 032724106 | LONG | 726,122 | $22.5 million |
| 11 | APELLIS PHARMACEUTICALS INC | COM · 03753U106 | LONG | 389,596 | $20.1 million |
| 12 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 49,200 | $18.6 million |
| 13 | BELLUS HEALTH INC NEW | COM NEW · 07987C204 | LONG | 4,112,494 | $33.8 million |
| 14 | BIOGEN INC | COM · 09062X103 | LONG | 252,542 | $69.9 million |
| 15 | BIOMARIN PHARMACEUTICAL INC | NOTE 0.599% 8/0 · 09061GAH4 | LONG | 9,000,000 | $9.6 million |
| 16 | BIOMARIN PHARMACEUTICAL INC | NOTE 1.250% 5/1 · 09061GAK7 | LONG | 19,200,000 | $20.7 million |
| 17 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 42,294,000 | $16.2 million |
| 18 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 141,500,000 | $63.7 million |
| 19 | COMPASS THERAPEUTICS INC | COM · 20454B104 | LONG | 1,814,266 | $9.1 million |
| 20 | COOPER COS INC | COM NEW · 216648402 | LONG | 52,115 | $17.2 million |
| 21 | CRINETICS PHARMACEUTICALS IN | COM · 22663K107 | LONG | 3,469,674 | $63.5 million |
| 22 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 1,246,539 | $26.8 million |
| 23 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J101 | LONG | 12,107,785 | $18.5 million |
| 24 | DECIPHERA PHARMACEUTICALS IN | COM · 24344T101 | LONG | 3,271,513 | $53.6 million |
| 25 | DICE THERAPEUTICS INC | COM · 23345J104 | LONG | 839,075 | $26.2 million |
| 26 | DYNE THERAPEUTICS INC | COM · 26818M108 | LONG | 753,145 | $8.7 million |
| 27 | EDWARDS LIFESCIENCES CORP | COM · 28176E108 | LONG | 235,319 | $17.6 million |
| 28 | ENANTA PHARMACEUTICALS INC | COM · 29251M106 | LONG | 325,838 | $15.2 million |
| 29 | ESPERION THERAPEUTICS INC NE | COM · 29664W105 | LONG | 3,393,405 | $21.1 million |
| 30 | EXACT SCIENCES CORP | NOTE 0.375% 3/0 · 30063PAC9 | LONG | 139,000,000 | $109.6 million |
| 31 | EXACT SCIENCES CORP | NOTE 0.375% 3/1 · 30063PAB1 | LONG | 48,300,000 | $40.1 million |
| 32 | FUSION PHARMACEUTICALS INC | COM · 36118A100 | LONG | 2,000,000 | $6.3 million |
| 33 | GLAUKOS CORP | COM · 377322102 | LONG | 1,661,851 | $72.6 million |
| 34 | GLOBUS MED INC | CL A · 379577208 | LONG | 343,626 | $25.5 million |
| 35 | GUARDANT HEALTH INC | NOTE 11/1 · 40131MAB5 | LONG | 250,022,000 | $156.7 million |
| 36 | HILLEVAX INC | COM · 43157M102 | LONG | 1,620,216 | $27.1 million |
| 37 | IMMATICS N.V | SHS · N44445109 | LONG | 1,250,052 | $10.9 million |
| 38 | IMMUNOGEN INC | COM · 45253H101 | LONG | 3,474,497 | $17.2 million |
| 39 | INSMED INC | NOTE 0.750% 6/0 · 457669AB5 | LONG | 10,000,000 | $8.3 million |
| 40 | INSMED INC | NOTE 1.750% 1/1 · 457669AA7 | LONG | 399,630,000 | $37.7 million |
| 41 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 223,120 | $59.2 million |
| 42 | INVITAE CORP | NOTE 2.000% 9/0 · 46185LAB9 | LONG | 21,500,000 | $17.0 million |
| 43 | IONIS PHARMACEUTICALS INC | NOTE 4/0 · 462222AD2 | LONG | 52,740,000 | $48.9 million |
| 44 | IONIS PHARMACEUTICALS INC | NOTE 0.125%12/1 · 462222AB6 | LONG | 36,533,000 | $33.4 million |
| 45 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 497,667 | $46.6 million |
| 46 | ITEOS THERAPEUTICS INC | COM · 46565G104 | LONG | 71,585 | $1.4 million |
| 47 | IVERIC BIO INC | COM · 46583P102 | LONG | 3,341,300 | $71.5 million |
| 48 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $49.4 million |
| 49 | KODIAK SCIENCES INC | COM · 50015M109 | LONG | 914,209 | $6.5 million |
| 50 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 358,056 | $28.4 million |
| 51 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 658,101 | $32.9 million |
| 52 | MERSANA THERAPEUTICS INC | COM · 59045L106 | LONG | 1,862,700 | $10.9 million |
| 53 | MERUS N V | COM · N5749R100 | LONG | 1,998,084 | $30.9 million |
| 54 | MILESTONE PHARMACEUTICALS IN | COM · 59935V107 | LONG | 1,164,849 | $4.6 million |
| 55 | MIRATI THERAPEUTICS INC | COM · 60468T105 | LONG | 413,600 | $18.7 million |
| 56 | MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD · 61559X104 | LONG | 381,120 | $4.0 million |
| 57 | NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 · 63009RAD1 | LONG | 145,520,000 | $118.2 million |
| 58 | NATERA INC | COM · 632307104 | LONG | 1,621,012 | $65.1 million |
| 59 | NEKTAR THERAPEUTICS | COM · 640268108 | LONG | 620,280 | $1.4 million |
| 60 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 48,678,000 | $31.9 million |
| 61 | NEOGENOMICS INC | NOTE 1.250% 5/0 · 64049MAA8 | LONG | 10,000,000 | $8.5 million |
| 62 | NEOGENOMICS INC | NOTE 1.250% 5/0 · 64049MAA8 | LONG | 33,000,000 | $28.0 million |
| 63 | NEVRO CORP | COM · 64157F103 | LONG | 1,192,298 | $47.2 million |
| 64 | NEVRO CORP | NOTE 2.750% 4/0 · 64157FAC7 | LONG | 109,251,000 | $100.2 million |
| 65 | NKARTA INC | COM · 65487U108 | LONG | 1,525,800 | $9.1 million |
| 66 | NOVOCURE LTD | NOTE 11/0 · 67011XAB9 | LONG | 131,834,000 | $117.6 million |
| 67 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 36,665,000 | $32.2 million |
| 68 | NUVASIVE INC | NOTE 1.000% 6/0 · 670704AL9 | LONG | 16,500,000 | $16.2 million |
| 69 | NUVATION BIO INC | COM CL A · 67080N101 | LONG | 4,122,900 | $7.9 million |
| 70 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 1,044,699 | $41.5 million |
| 71 | OUTSET MED INC | COM · 690145107 | LONG | 1,704,552 | $44.0 million |
| 72 | PENUMBRA INC | COM · 70975L107 | LONG | 162,828 | $36.2 million |
| 73 | PROTAGONIST THERAPEUTICS INC | COM · 74366E102 | LONG | 927,800 | $10.1 million |
| 74 | PULMONX CORP | COM · 745848101 | LONG | 1,621,494 | $13.7 million |
| 75 | QUIDELORTHO CORP | COM · 219798105 | LONG | 300,437 | $25.7 million |
| 76 | RAPT THERAPEUTICS INC | COM · 75382E109 | LONG | 1,000,000 | $19.8 million |
| 77 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 662,349 | $18.0 million |
| 78 | SAREPTA THERAPEUTICS INC | COM · 803607100 | LONG | 140,352 | $18.2 million |
| 79 | SILK RD MED INC | COM · 82710M100 | LONG | 416,817 | $22.0 million |
| 80 | STERIS PLC | SHS USD · G8473T100 | LONG | 95,694 | $17.7 million |
| 81 | SUPERNUS PHARMACEUTICALS | NOTE 0.625% 4/0 · 868459AD0 | LONG | 6,500,000 | $6.4 million |
| 82 | SYNDAX PHARMACEUTICALS INC | COM · 87164F105 | LONG | 1,242,802 | $31.6 million |
| 83 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 303,185 | $18.7 million |
| 84 | TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 · 89422GAA5 | LONG | 3,000,000 | $2.7 million |
| 85 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 50,536,000 | $46.6 million |
| 86 | TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 · 89422GAA5 | LONG | 28,350,000 | $25.9 million |
| 87 | TRAVERE THERAPEUTICS INC | COM · 89422G107 | LONG | 1,455,585 | $30.6 million |
| 88 | VAXCYTE INC | COM · 92243G108 | LONG | 1,362,278 | $65.3 million |
| 89 | VIRIDIAN THERAPEUTICS INC | COM · 92790C104 | LONG | 313,403 | $9.2 million |
| 90 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 1,548,110 | $61.0 million |